No, you should not stop amantadine suddenly. Abrupt discontinuation can trigger a serious reaction that includes high fever, severe muscle rigidity, rapid heart rate, and altered mental status. These symptoms resemble a condition called neuroleptic malignant syndrome and can be life-threatening. The safe approach is a gradual taper under medical supervision.
Why Stopping Suddenly Is Dangerous
Amantadine works in the brain by boosting dopamine release and blocking its reabsorption, which helps manage symptoms of Parkinson’s disease, involuntary movements, and certain other conditions. When you stop taking it abruptly, your brain loses that dopamine support all at once. The result can be a rapid, dangerous shift in how your nervous system functions.
The most serious risk is a cluster of symptoms that mirrors neuroleptic malignant syndrome: high fever, whole-body muscle rigidity, sweating, rapid heart rate, and confusion or unresponsiveness. In the medical literature, this is sometimes called parkinsonism-hyperpyrexia syndrome (PHS), and while rare, it is potentially fatal. The presentation can also fall on a spectrum, with milder cases showing delirium or a catatonia-like state rather than the full syndrome. In one documented case, a 75-year-old patient developed catatonic delirium after amantadine was discontinued.
Since 1987, only about 15 patients across seven published case reports have been formally documented with amantadine withdrawal syndrome. That makes it rare, but the severity of the reaction is what matters. The low number of reports also likely reflects underrecognition, since the symptoms can be mistaken for other conditions, including infections or encephalopathy.
What Withdrawal Symptoms Feel Like
In a study of 30 patients who stopped amantadine, 24 experienced worsening symptoms within an average of 3.6 days. The most common complaints were motor problems (tremor, stiffness, clumsiness, difficulty walking) and nonmotor symptoms like pain and general weakness. Given amantadine’s half-life of 10 to 14 hours, withdrawal effects can begin as early as one day after the last dose.
Six patients in that same study reported no worsening at all after stopping amantadine for up to eight weeks. So the experience varies, but there’s no reliable way to predict in advance whether you’ll be in the majority who struggle or the minority who tolerate it without issue. That unpredictability is exactly why a supervised taper is the standard approach.
At the more serious end, withdrawal can cause confusion, disorientation, and changes in consciousness that may be difficult to distinguish from other neurological emergencies. Caregivers and family members should be aware of these possibilities if a taper is underway.
How to Taper Safely
Published guidelines recommend reducing amantadine by 50 mg every second or third day. In one clinical trial (the AMANDYSK trial), 29 patients tapered by 100 mg every other day without significant adverse events, though some experienced a return of involuntary movements. The slower 50 mg reduction gives your brain more time to adjust and is the more cautious option.
The exact schedule depends on your current dose, how long you’ve been taking amantadine, and what condition it’s treating. Your prescriber will set a timeline based on these factors. If you’re taking other Parkinson’s medications alongside amantadine, the taper may need to account for how those drugs interact during the transition.
What to Watch For During a Taper
Even with a gradual reduction, it’s worth monitoring for warning signs. The key symptoms to take seriously are:
- Fever: especially if it comes on without an obvious cause like an infection
- Muscle stiffness: a noticeable increase in rigidity beyond your baseline
- Mental status changes: new confusion, agitation, or unusual drowsiness
- Rapid heart rate or heavy sweating: signs of autonomic instability
If any of these develop, contact your prescriber promptly. In the studies that tracked withdrawal, patients who developed symptoms were instructed to restart amantadine and typically recovered once the medication was resumed. The earlier the reaction is caught, the simpler it is to manage.
For people with Parkinson’s disease specifically, the return of motor symptoms like tremor and stiffness is expected during a taper and doesn’t necessarily signal a dangerous withdrawal reaction. The distinction is that a true withdrawal syndrome involves systemic signs like fever and altered consciousness, not just a return of your usual movement symptoms.